Nitric oxide mediated endothelium-dependent relaxation induced by glibenclamide in rat isolated aorta

Cardiovasc Res. 2000 Apr;46(1):180-7. doi: 10.1016/s0008-6363(99)00423-x.

Abstract

Objectives: Glibenclamide was found to act as both a selective ATP-sensitive K(+) channel blocker and a vasorelaxant. The exact mechanisms underlying the relaxant effect of glibenclamide are unknown. The present study was designed to examine the role of endothelium/nitric oxide in glibenclamide-induced relaxation in rat isolated aortic rings.

Methods: A combination of experimental approaches including isometric force measurement, cell culture, Ca(2+) fluorescence measurement and radioimmunoassay were used to examine the vascular effect of glibenclamide.

Results: Glibenclamide induced a concentration-dependent relaxation more effectively in rings with endothelium (IC(50) of 32+/-4 microM) than those without endothelium (IC(50) of 365+/-29 microM). Incubation with N(G)-nitro-L-arginine methyl ester (L-NAME) or methylene blue significantly reduced and L-arginine (3 mM) potentiated the glibenclamide-induced relaxation. L-Arginine (3 mM) partially antagonized the effect of L-NAME. Glibenclamide (100 microM) increased the cyclic GMP content of endothelium-intact tissues. Pretreatment with N(G)-nitro-L-arginine (100 microM) or removal of endothelium significantly suppressed the effect of glibenclamide on cyclic GMP production. Glibenclamide elevated the intracellular Ca(2+) levels in cultured rat aortic endothelial cells. Glibenclamide also inhibited the endothelium-independent contractile response to 60 mM K(+) (IC(50) of 137+/-21 microM) and caused a rightward shift in the concentration-contraction curve for CaCl(2). Besides, glibenclamide inhibited phorbol-12,13-diacetate (1 microM)-induced contraction in Ca(2+)-free Krebs solution.

Conclusion: These results indicate that glibenclamide-induced endothelium-dependent relaxation involves nitric oxide release and this effect may be related to its stimulatory effect on endothelial Ca(2+) levels. However, the glibenclamide-induced endothelium-independent relaxation may be associated with its inhibitory effect on Ca(2+) influx through Ca(2+) channels and on the protein kinase C-mediated contractile mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta
  • Arginine / pharmacology
  • Calcimycin / pharmacology
  • Calcium Chloride / pharmacology
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Egtazic Acid / pharmacology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Glyburide / pharmacology*
  • Male
  • Methylene Blue / pharmacology
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitroprusside / pharmacology
  • Phenylephrine / pharmacology
  • Protein Kinase C / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Tetradecanoylphorbol Acetate / pharmacology
  • Vasoconstrictor Agents / pharmacology
  • Vasodilator Agents / pharmacology*

Substances

  • Enzyme Inhibitors
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Nitroprusside
  • Phenylephrine
  • Nitric Oxide
  • Calcimycin
  • Egtazic Acid
  • Arginine
  • Nitric Oxide Synthase
  • Protein Kinase C
  • Calcium Chloride
  • Tetradecanoylphorbol Acetate
  • Glyburide
  • Methylene Blue
  • NG-Nitroarginine Methyl Ester